 |
|
|
|
 |
| September 10 ,
2009 | ISSUE NUMBER 115 VOL 6 |
Legal
Sepracor Faces Shareholder Lawsuit in Wake of $2.6B Deal
Some shareholders think they were shafted in the multi-billion dollar deal between Sepracor and Dainippon Sumitomo Pharma. They’re so miffed, in fact, that they’ve filed a lawsuit stating that the amount offered undervalues the company and its shares.
People
Roche Shifts Execs in Anticipation of Departures
With the pending retirement of three senior-level executives, Roche announced a new corporate executive team to bridge the personnel gap while the company looks for new leaders.
Technology
Hot Topics in Supply Chain Management
Times are changing in the pharmaceutical and life sciences sectors, and the supply chains have to adapt to a new set of challenges, says Kenneth Porter of specialist consultancy Total Logistics.
Global
UK Pharmacies Dealing with Drug Shortages
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
|
 |
 |
|  Clarian Health promoted Sheriee Ladd to senior vice president of human resources //
AbelsonTaylor promoted Brandi Homan and Kathleen Burzycki to copywriter //
SCOLR Pharma appointed Stephen J. Turner as CEO and president //
Physicians Interactive named Sanjay Pingle president //
Ferguson, the founding agency of CommonHealth, launched the OTC Center of Excellence to address the rapid increase of promotion and use of OTC drugs //
AmerisourceBergen Packaging Group named Rosalyn Wesley vice president of human resources //
Satori Pharmaceuticals named Steven Holtzman, CEO and co-founder of Infinity Pharmaceuticals, to its board of directors //
Sinapis Pharma made Frederick Frank consultant to the company //
KV Pharmaceutical made Thomas McHugh interim chief financial officer //
|
September
10 An Evolving Standard for Success: Proving Product Value Through Comparative Effectiveness Data
Wednesday, September 10 at 11 AM EDT
September 14 Develop Competitive Advantage Through Business Analytics in the New Pharmaceutical Commercial Model
Wednesday, September 23, 2009 at 11:00 AM EDT
September 23 Mining Business and Technology Best Practices: Winning Strategies for the E-Commerce Space
Wednesday, September 14 at 11 AM EDT
September 24 Drugs, Devices or Data – Which is Most Valuable? An Expert Panel Debates
Thursday, September 24, 2009 at 2:00 PM EDT
|
|
|
September
14–15 4th Annual Forum on Educational Grants for the Bio/Pharmaceutical Industry,
Philadelphia, PA
September
21–24 5th
Annual Process Excellence Week for the Service & Transactional
World, Chicago, IL
September
30 Prix Galien 2009 Awards Ceremony, New York, NY
October
5–7 BioNetwork
2009: The 7th Annual Pharmaceutical-Biotech Partnering
Conference, Laguna Niguel, California
October
20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA |
|
|
|
 |
|
 |
|
 |
| Is Merck doing a good job integrating Schering-Plough executives into the "New Merck"? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
